Skip to content

SCHEDULE 13DAccepted Jun 10, 9:32 PM ET

InMed Pharmaceuticals Inc. SCHEDULE 13D

Vivo Opportunity Fund Holdings, L.P.

Accepted (ET)

9:32 PM

Jun 10, 2026

Filed

Jun 10, 2026

Documents

2

Size

26.4 KB

Summary

Summary not available

This filing does not have a written summary yet. You can still open the original filing and its exhibits.